Ezkerralde-Enkarterri-Gurutzetako Erakunde Sanitario Integratua
Osakidetzako erakundea
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosNational Institute of Allergy and Infectious Diseases-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays
PLoS Pathogens, Vol. 20, Núm. 9
-
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Human Genetics and Genomics Advances, Vol. 5, Núm. 3
2023
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
2020
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2015
-
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)–associated inflammatory diseases
Journal of Allergy and Clinical Immunology, Vol. 136, Núm. 5, pp. 1337-1345